¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hypoglycemic shock therapy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® symptomatic therapy ÇÑ±Û ´ëÁõ¿ä¹ý
¼³¸í   
  º´ÀÇ ¿øÀÎÀ» Ã£¾Æ ¾ø¾Ö±â °ï¶õÇÑ »óȲ¿¡¼­, °ÑÀ¸·Î ³ªÅ¸³­ º´ÀÇ Áõ»ó¿¡ ´ëÀÀÇÏ¿© Ã³Ä¡¸¦ Çϴ ġ·á¹ý. ¿­ÀÌ ³ôÀ» ¶§¿¡ ¾óÀ½ÁָӴϸ¦ ´ë°Å³ª ÇØ¿­Á¦¸¦ ½á¼­ ¿­À» ³»¸®°Ô Çϴ µûÀ§°¡ ÀÌ¿¡ ¼ÓÇÑ´Ù. 
¿µ¹® radiation therapy ÇÑ±Û ¹æ»ç¼±¿ä¹ý
¼³¸í   
  X¼±, ¥ã¼±ÀÇ ÀüÀÚ¹æ»ç¼±À̳ª ÀüÀÚ¼±, ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÇ ÀÔÀÚ¹æ»ç¼±À» ÀÌ¿ëÇØ, ÁַΠ¾Ç¼º Á¾¾ç Ä¡·á¸¦ ¸ñÀûÀ¸·Î Çϴ ġ·á¹ýÀÌ´Ù. ¾Ï¼¼Æ÷°¡ ÁÖÀ§ÀÇ Á¤»ó¼¼Æ÷º¸´Ùµµ ¹æ»ç¼± °¨¼ö¼ºÀÌ ³ôÀº Á¡À» ÀÌ¿ëÇÏ¿©, Á¤»ó¼¼Æ÷ÀÇ ¼Õ»óÀ» °¡´ÉÇÑ ÇÑ ÃּҷΠ¾ïÁ¦Çϸ鼭 ¾Ï¼¼Æ÷¸¦ ÆÄ±«ÇÑ´Ù. »ç¿ëµÇ´Â ¹æ»ç¼±¿¡´Â ¹ÐºÀ¼Ò¼±¿ø¿¡¼­ ³ª¿À´Â ¥ã¼±, Á÷¼±°¡¼Ó±â¿¡¼­ ¾ò¾îÁö´Â °í¿¡³ÊÁö X¼±°ú ÀüÀÚ¼±, ÅÚ·¹ÄÚ¹ßÆ®ÀåÄ¡¿¡ ÀÇÇÑ 60CoÀÇ ¥ã¼±°ú, º£Å¸Æ®·Ð¿¡ ÀÇÇÑ ÀüÀÚ¼±, »çÀÌÅ©·ÎÆ®·Ð¿¡¼­ ¾ò¾îÁö´Â ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÌ ÀÖ´Ù. 
¿µ¹® radiation therapy ÇÑ±Û ¹æ»ç¼±Ä¡·á
¼³¸í   
  ¹æ»ç¼±ÀÇ »ì±ÕÈ¿°ú³ª ¼¼Æ÷¸¦ Á×À̴ ȿ°ú¸¦ Ä¡·á¿¡ ÀÌ¿ëÇϴ ¹æ¹ýÀ¸·Î, Á¼Àº Àǹ̷Π¾ÏÀÇ ¹æ»ç¼±Ä¡·á¸¦ ÀǹÌÇÑ´Ù. ¾Ï¿¡ ´ëÇÑ ¹æ»ç¼±Ä¡·á´Â ¾Ï¼¼Æ÷¸¦ Á×À̴µ¥ È¿°ú°¡ Å« º£Å¸¼±À» ÁַΠ»ç¿ëÇÑ´Ù. ÇÏÁö¸¸, ÀÌ·± ¹æ»ç¼±Ä¡·á´Â Á¤»ó¼¼Æ÷¿¡µµ Å« ¿µÇâÀ» ³¢ÃÄ ÀÌ¿¡ µû¸¥ ±â´ÉÀÇ Àå¾Ö¸¦ °¡Á®¿Ã ¼ö ÀÖ´Ù. µû¶ó¼­ ¹æ»ç¼±Ä¡·á¿¡ À־´Â ´ÜÁö ±× ¾Ï¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ë»Ó¸¸ ¾Æ´Ï¶ó, Á¤»ó¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ëµµ °í·ÁÇÏ¿© ½ÃÇàÇÑ´Ù.
¿µ¹® speech therapy ÇÑ±Û ¾ð¾îÄ¡·á
¼³¸í   
  ¸»À» Á¤È®ÇϰԠ¹ßÀ½ÇÒ ¼ö ¾ø°Å³ª ´õµë´Â È¯ÀÚ¿¡°Ô ¹ßÀ½, ´ëÈ­ µûÀ§ÀÇ ÈÆ·ÃÀ» Àü¹®ÀûÀ¸·Î ÇàÇϴ ġ·á¹ý. 
¿µ¹® therapy ÇÑ±Û ¿ä¹ý
¼³¸í   
  º´À» ³´°Ô Çϴ °Í ¶Ç´Â ±× ¹æ¹ý.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypovolemic shock
    ÀúÇ÷·®¼îÅ©
  • heat shock
    ¿­¼îÅ©
  • heat shock response
    ¿­Ãæ°Ý¹ÝÀÀ
  • heat-shock protein
    ¿­Ãæ°Ý´Ü¹éÁú
  • hematogenic shock
    ÀúÇ÷·®¼îÅ©
  • hemorrhagic shock
    ÃâÇ÷¼îÅ©
  • irreversible shock
    ºñ°¡¿ª¼îÅ©
  • induced shock
    À¯µµ¼îÅ©
  • insulin shock
    Àν¶¸°¼îÅ©
  • neurogenic shock
    ½Å°æ¼º¼îÅ©
  • osmotic shock
    »ïÅõ¾ÐÃæ°Ý
  • postoperative shock
    ¼ö¼úÈļîÅ©
  • pain shock
    ÅëÁõ¼îÅ©
  • spinal shock
    ô¼ö¼îÅ©
  • streptococcal toxic shock syndrome
    »ç½½¾Ë±Õµ¶¼º¼îÅ©ÁõÈıº, ¿¬¼â±¸±Õµ¶¼º¼îÅ©ÁõÈıº
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • initial therapy
    ÃʱâÄ¡·á
  • O2 therapy
    »ê¼Ò¿ä¹ý
  • radiation therapy
    ¹æ»ç¼±¿ä¹ý, ¹æ»ç¼±Ä¡·á
  • replacement therapy
    ´ëÄ¡¿ä¹ý
  • speech therapy
    ¾ð¾îÄ¡·á
  • supportive therapy
    ÁöÁö¿ä¹ý
  • symptomatic therapy
    ´ëÁõ¿ä¹ý
  • systemic therapy
    Àü½Å¿ä¹ý
  • thrombolytic therapy
    Ç÷Àü¿ëÇØ¿ä¹ý
  • topical therapy
    ±¹¼Ò¿ä¹ý
  • work therapy
    ÀÛ¾÷¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diastolic shock
    È®Àå±â¼îÅ©, À̿ϱâ¼îÅ©
  • direct current shock
    Á÷·ùÀü°Ý¼îÅ©
  • dye shock
    »ö¼ÒÃæ°Ý
  • electric shock
    Àü±âÃæ°Ý
  • endotoxin shock
    ³»µ¶¼Ò¼îÅ©
  • extracorporeal shock wave lithotripsy
    ¸ö¹ÛÃæ°ÝÆÄµ¹±þ¼ú, ü¿ÜÃæ°ÝÆÄ¼â¼®¼ú
  • gram negative shock
    ±×·¥À½¼º¼îÅ©
  • heat shock
    ¿­Ãæ°Ý
  • heat shock response
    ¿­Ãæ°Ý¹ÝÀÀ
  • heat-shock protein
    ¿­Ãæ°Ý´Ü¹é
  • hematogenic shock
    (¢¡hypovolemic shock) Ç÷¾×·®°¨¼Ò¼îÅ©
  • hemorrhagic shock
    ÃâÇ÷¼îÅ©
  • hyperglycemic shock
    °íÇ÷´ç¼îÅ©
  • hypovolemic shock
    Ç÷¾×·®°¨¼Ò¼îÅ©
  • induced shock
    À¯µµ¼îÅ©
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hematogenic shock
    ¿Ü¤ÁÇ÷Ç༺ ¼ï.
  • hemorrhage shock
    ÃâÇ÷¼º(õóúìàõ) ¼îÅ©
  • hemorrhagic shock
    ÃâÇ÷¼º¼ï
  • hyperglycemic shock
    °íÇ÷´ç¼º ¼ï.
  • hypovolemic shock
    (¼øÈ¯)Ç÷¾×·®°¨¼Ò¼º¼ï.
  • hypovolemic shock
    (¼øÈ¯)Ç÷¾×·®°¨¼Ò¼º¼ï
  • induced shock
    À¯µµ(ë¯Óô)¼ï.
  • induction shock
    À¯µµ¼ï.
  • insulin shock
    Àν¶¸°¼ï.
  • insulin shock treatment
    Àν¶¸°Ãæ°ÝÄ¡·á.
  • post electric shock syndrome
    Àü°Ý(ï³Ìª)¼ïÈÄÁõÈıº(¡­ý­ñøý¦ÏØ)
  • postelectric shock syndrome
    Àü°Ý¼ïÈÄÁõÈıº.
  • postoperative shock
    (¼ö)¼úÈļï.
  • postoperative shock
    (¼ö)¼úÈļï((â¢)âúý­¡­)
  • Chelation therapy
    ų·¹ÀÌÆ® ¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bacterial shock
    ¼¼±Õ¼º ¼ï
  • cardiogenic shock
    ½ÉÀμº ¼ï.
  • cardiogenic shock
    ½ÉÀμº¼ï (ãýì×àõ - )
  • cardiogenic shock
    ½ÉÀμº(ãýì×àõ)¼ï
  • cardiogenic shock
    ½ÉÀμº ¼ï(ãýì×àõ ¡­)
  • circulatory shock
    ¼øÈ¯¼º(âàü»àõ) ¼ï
  • circulatory shock
    ¼øÈ¯¼º ¼ï.
  • cold osmotic shock
    ÇÑ·©»ïÅõ¾Ð Ãæ°Ý
  • conditioning shock =c. stimulus
    Á¶°ÇÀÚ±Ø.
  • counter shock
    ¿ªÃæ°Ý, Ä«¿îÅͼï.
  • culture shock
    ¹®È­Ãæ°Ý(Ùþûùõú̪)
  • diastolic shock
    È®Àå±â¼ï.
  • direct current shock
    Á÷·ùÀü°Ý¼ï.
  • direct current shock
    Á÷·ùÀü±Ø¼ï.
  • drug shock
    ¾à¹°Ãæ°Ý(¡­õú̪).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GT gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm...
RT radiologic technologist; radiotelemetry; radiotherapy; radium therapy; rapid tranquilization; reacti...
CST cardiac stress test; cavernous sinus thrombosis; certified surgical technologist; chemostatin; Chris...
EST electric shock threshold; electroshock therapy; endometrial sinus tumor; endoscopic sphincterectomy;...
IST inappropriate sinus tachycardia; insulin sensitivity test; insulin shock therapy; International Soci...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CSP cold shock protein
DHF/DSS Dengue Haemorrhagic Fever/Dengue Shock Syndrome
DSS Dengue Shock Syndrome
ECS Electroconvulsive shock
HS Heat Shock
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • post electric shock syndrome
    Àü°Ý ¼ï ÈÄ ÁõÈıº
  • primary shock
    ÀÏÂ÷¼º ¼ï
  • semi-shock
    ¹Ý¼îÅ©
    ´ë»ó ±â±¸°¡ ÀÛ¿ëÇØ, °Ü¿ì ¼îÅ©¸¦ ¸éÇÏ´Â °æ¿ì.
  • shock
    ¼ï
    1. ½Åü ÆòÇüÀÇ °©ÀÛ½º·¯¿î Àå¾Ö. 2. ÁÖ¿ä Àå±â¿¡ ´ëÇÑ Ç÷·ù À¯Áö¸¦ À§ÇÑ ¼øÈ¯°èÀÇ, ±â´É »ó½Ç·Î Ư¡ Áö¿öÁö´Â ½É°¢ÇÑ Ç÷¾× ¼øÈ¯°ú ´ë»çÀÇ ¹æÇØ Á¶°Ç. ÀÌ´Â Ç÷¾×·®ÀÇ ÀúÇÏ·Î ¹ß»ýÇÒ ¼öµµ ÀÖ°í, ½É±â´É ÀúÇÏ È¤Àº ºñÁ¤»óÀûÀÎ vasomotor toneÀ¸·Î ÀÎÇÑ °æ¿ìµµ ÀÖ´Ù. ÀúÇ÷¾Ð, ÇǺÎÀÇ ÇÑ·©, Åë»óÀº ºó¸Æ, Á¾Á¾ ºÒ¾ÈÀ» Ư¡À¸·Î ÇÑ´Ù.
  • shock circuit reaction
    ´Ü¶ô ¹ÝÀÀ
    °¨Á¤Àû Ãæµ¿ÀÌ À̼ºÀÇ ÅëÁ¦¸¦ ¹þ¾î³ª Á÷Á¢À¸·Î Çൿ¿¡ ¿Å°ÜÁö´Â ¹ÝÀÀ.
  • shock kidney
    ¼îÅ©¼º ½Å ±â´É Àå¾Ö
    ¼îÅ©¿¡ ºüÁ® Ç÷¾Ð ÀúÇϰ¡ ±æ°Ô À̾îÁ® ½Å Ç÷·ù·®ÀÌ °¨¼ÒÇÏ¿© »ý±ä ±Þ¼º ½Å ºÎÀü.
  • shock lung
    ¼îÅ© Æó
    ÃâÇ÷¼º ¼îÅ© µî¿¡ ÇÕº´Çϴ ȣÈí ºÎÀü.
  • shock position
    ¼ï À§Ä¡
    ȯÀÚ°¡ ¼îÅ©¸¦ ÀÏÀ¸Ä×À» ¶§ ±× ±¸±Þ üÀ§·Î¼­ ÃëÇØÁö´Â üÀ§.
  • shock shortening heat
    ´ÜÃà ¿­
    ´ÜÃàÇÏ´Â ±æÀÌ¿¡ ºñ·ÊÇØ ºÎÇÏ¿¡ °ü°è¾øÀÌ ¹ß»ýÇÏ´Â ¿­.
  • shock term memory
    ´Ü±â ±â¾ï
  • shock treatment
    ¼ï Ä¡·á
    Ä«¸£µð¾ÆÁ¹ °æ·Ã ¿ä¹ý, Àü±â ¼îÅ© ¿ä¹ý, Àν¶¸° ¼îÅ© ¿ä¹ý µîÀÌ ÀÖ´Ù.
  • shock wave imaging
    Ãæ°ÝÆÄ »ó
  • state of shock
    Ãæ°Ý »óÅÂ
  • wound shock
    ¿Ü»ó¼º ¼ï
  • acrylic splint therapy
    ¾ÆÅ©¸± ¾ÈÁ¤ ±³ÇÕ»ó Ä¡·á
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
primary shock Shock mainly nervous in nature, from pain, anxiety, etc., which ensues almost immediately upon the receipt of a severe injury.
(05 Mar 2000)
heat-shock factor <cell biology, protein> A class of molecular chaperones found in both prokaryotes and in several compartments of eukaryotic cells. There is evidence that these proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures.
(12 Dec 1998)
Previous: heat-shock factor, heat-shock gene, heat-shock protein, heat-shock protein 27 kinaseNext: heat-shock proteins 90, heat-shock responseheat-shock factor -->heat-shock proteins 90
<cell biology, protein> A class of molecular chaperones whose members act in the mechanism of signal transduction by steroid receptors.
(12 Dec 1998)
heat-shock gene <molecular biology> A set of genes present in most animals which are transcribed suddenly, quickly, and with coordination when the animal is exposed to certain types of stress such as a sudden temperature increase.
(09 Oct 1997)
heat-shock protein <cell biology, molecular biology, protein> Families of proteins conserved through prokaryotic and eukaryotic cells and bacteria in response to hyperthermia and other environmental stresses, although some are constitutively expressed. They increase thermal tolerance and perform functions essential to cell survival under these conditions.
Some serve to stabilise proteins in abnormal configurations, play a role in folding and unfolding of proteins and the assembly of oligomeric complexes and may act as chaperonins. Hsp90 complexes with inactive steroid hormone receptor and is displaced upon ligand binding.
Four major sub classes are recognised: hsp90, hsp70, hsp60 and small hsps. Hsps have been suggested to act as major immunogens in many infections.
Acronym: HSP
(12 Dec 1998)
heat-shock protein 27 kinase <enzyme> Phosphorylates hsp 26 on serine residues when stimulated by tumour necrosis factor or interleukin 1
Registry number: EC 2.7.1.-
Synonym: hsp 27 kinase, heat-shock protein 27 kinase, hsp27 kinase
(26 Jun 1999)
heat-shock proteins 70 <cell biology, protein> A class of molecular chaperones found in both prokaryotes and in several compartments of eukaryotic cells. There is evidence that these proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures.
(12 Dec 1998)
heat-shock proteins 90 <cell biology, protein> A class of molecular chaperones whose members act in the mechanism of signal transduction by steroid receptors.
(12 Dec 1998)
heat-shock response <cell biology> A constellation of responses that occur when an organism is exposed to excessive heat and other environmental stresses. Responses include synthesis of some proteins, repression of other proteins, and expression of new proteins.
(12 Dec 1998)
heat-shock response element <cell biology, protein> The nucleotide sequence, CNNGAANNTCCNG, which is in the promoter region of the heat-shock genes. When the animal is exposed to certain types of stress such as a sudden rise in temperature, the first thing that happens to activate these genes is the binding of the HSE by a transcriptional enhancer protein.
(09 Oct 1997)
protein shock The systemic reaction following the parenteral administration of a protein.
(05 Mar 2000)
pseudoanaphylactic shock A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions.
Synonym: anaphylactoid crisis, pseudoanaphylactic shock.
(05 Mar 2000)
high-energy shock waves Compression waves of large amplitude, across which density, pressure, and particle velocity change drastically.
(12 Dec 1998)
histamine shock The shock state produced in animals by the injection of histamine; characterised by bronchiolar spasm in the guinea pig and constriction of hepatic veins in the dog.
(05 Mar 2000)
septic shock <microbiology> Condition of clinical shock caused by endotoxin in the blood.
A serious complication of severe burns and abdominal wounds, frequently fatal. Part of the problem seems to be due to increased leucocyte adhesiveness, which leads to massive sequestration of neutrophils in the lung, increased vascular permeability and acute respiratory distress syndrome.
(11 Jan 1998)
serum shock Anaphylactic or anaphylactoid shock caused by the injection of antitoxic or other foreign serum.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • shock action
    Ãæ°Ý
  • shock dog
    »ð»ì°³
  • shock stall
    Ãæ°ÝÆÄ ½Ç¼Ó
  • shock troops
    Ư°ø´ë
  • shock wave
    Ãæ°ÝÆÄ
  • therapy
    Ä¡·á; ¿ä¹ý
  • Xray therapy
    ¿¢½º¼± ¿ä¹ý
  • cell therapy
    ¼¼Æ÷¿ä¹ý(¾çÀÇ °«³­»õ³¢ÀÇ ¼¼Æ÷¸¦ ÁÖÀÔÇϴ ȸÃá¹ý ('
  • cellar therapy
    =CELL THERAPY
  • deep therapy
    ½ÉºÎ X¼± Ä¡·á(ÁÖ´ë»óÀº ¾Ç¼º Á¾¾ç)
  • electroconvulsive therapy
    =ELECTROSHOCK THERAPY
  • electroshock therapy
    (Á¤ÀÇ)Àü±â ¼îÅ©(Ãæ°Ý)¿ä¹ý
  • family therapy
    °¡Á· ¿ä¹ý
  • fever therapy
    ¹ß¿­ ¿ä¹ý
  • fever therapy
    ¹ß¿­¿ä¹ý
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á